Although CD36-expressing cells in the above study could not be related to EMT, we provide evidence that neutralizing anti-CD36 antibodies could also prevent LD formation in acidosis-adapted cancer cells, making this strategy particularly suited to prevent TGF-β2-driven tumor progression. The gene discussed is CD36; the disease is cancer.